1,201
Views
40
CrossRef citations to date
0
Altmetric
Review

Fertility after uterine artery embolization: a review

, &
Pages 1-7 | Received 03 Nov 2014, Accepted 15 Jun 2015, Published online: 29 Aug 2015

References

  • McLucas B. Pregnancy following uterine artery embolization: an update. Minim Invas Ther Allied Technol. 2013;22:39–44.
  • Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105:67–76.
  • Ravina JH, Vigneron NC, Aymard A, Le Dref O, Merland JJ. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril. 2000;73:1241–3.
  • Bonduki CE, Feldner Jr PC, Silva J, Castro RA, Sartori MG, Girao MJ. Pregnancy after uterine arterial embolization. Clinics. 2011;66:807–10.
  • Kim MD, Kim NK, Kim HJ, Lee MH. Pregnancy following uterine artery embolization with polyvinyl alcohol particles for patients with uterine fibroid or adenomyosis. CVIR. 2005;28:611–15.
  • Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012;12:6.
  • Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–7.
  • Chen C, Buck G, Courey N, Perez K, Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol. 2001;153:20–6.
  • Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001;153:1–10.
  • Marsh EE, Ekpo GE, Cardozo ER, Brocks M, Dune T, Cohen LS. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study. Fertil Steril. 2013;99:1951–7.
  • Baird DD. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol. 2004;159:124–6.
  • Fields KR, Neinstein LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol. 1996;9:195–8.
  • McLucas B, Adler L. Uterine fibroid embolization compared with myomectomy. Int J Gynecol Obstet. 2001;74:297–9.
  • Divakar H. Asymptomatic uterine fibroids. Best Pract Res Cl Ob. 2008;22:643–54.
  • Gambadauro P. Dealing with uterine fibroids in reproductive medicine. J Obstet Gynaecol. 2012;32:210–16.
  • Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346:671–2.
  • Reidy JF, Bradley EA. Uterine artery embolization for fibroid disease. J Cardiovasc Interv Radiol. 1998;21:357–60.
  • Walker WJ, Barton-Smith P. Long-term follow up of uterine artery embolisation—an effective alternative in the treatment of fibroids. BJOG. 2006;113:464–8.
  • Razavi MK, Wolanske KA, Hwang GL, Sze DY, Kee ST, Dake MD. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology. 2002;224:707–12.
  • Beavis ELG, Brown JB, Smith MA. Ovarian Function after Hysterectomy with conservation of the ovaries in pre-menopausal women. BJOG. 1969;76:969–78.
  • Chrisman HB, Saker MB, Ryu RK, Nemcek Jr AA, Gerbie MV, Milad MP, et al. The Impact of Uterine Fibroid Embolization on Resumption of Menses and Ovarian Function. J Vasc Interv Radiol. 2000;11:699–703.
  • de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–62.
  • van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83:979–87.
  • Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, et al. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet. 2011;283:1415–21.
  • Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747–50.
  • Ji Hee Yoo HOK. Sun Wha Cha, Chan Woo Park, Kwang Moon Yang, In Ok Song, Mi Kyoung Koong, Inn Soo Kang. Age specific Anti-Mullerian hormone levels in 1,298 Korean women with regular menstruation. Clin Exp Reprod Med. 2011;38:93–7.
  • Wang MH, Chen CH, Wang CW, Hsu MI, Tzeng CR. A higher anti-Mullerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination. J Obstet Gynaecol 2014:1–5.
  • Grynnerup AGA, Lindhard A, SØRensen S. The role of anti-Müllerian hormone in female fertility and infertility – an overview. Acta Obstet Gynecol Scand. 2012;91:1252–60.
  • Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99:1644–53.
  • van Rooij IAJ, Tonkelaar ID, Broekmans FJM, Looman CWN, Scheffer GJ, de Jong FH, et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11(6, Part 1 of 2):601–6.
  • Johannes CB, Crawford SL. Menstrual Bleeding, Hormones, and the Menopausal Transition. Semin Reprod Med. 1999;17:299–309.
  • Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause–a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand. 1999;78:642–7.
  • Tropeano G, Di Stasi C, Amoroso S, Gualano MR, Bonomo L, Scambia G. Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study. Fertil Steril. 2010;94:2296–300.
  • Rashid S, Khaund A, Murray LS, Moss JG, Cooper K, Lyons D, et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. BJOG. 2010;117:985–9.
  • Hehenkamp WJK, Volkers NA, Broekmans FJM, de Jong FH, Themmen APN, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005.
  • Tulandi T, Salamah K. Fertility and uterine artery embolization. Obstet Gynecol. 2010;115:857–60.
  • Arthur R, Kachura J, Liu G, Chan C, Shapiro H. Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. JOGC. 2014;36:240–7.
  • McLucas B, Danzer H, Wambach C, Lee C. Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report. Minim Invas Ther Allied Technol. 2013;22:45–9.
  • Mclucas B, Voorhees WDIII, Chua K. Anti Müllerian Hormone Levels Before and After Uterine Artery Embolization: A Preliminary Report. Minim Invas Ther Allied Technol. 2015;24:242–5.
  • Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CC, et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94:786–92.
  • Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M, et al. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol. 2005;106:1309–18.
  • Carranza-Lira S, Bustamante-Mendoza JA, Leanos-Miranda A, Campos-Galicia I, Estrada-Moscoso I, Chan-Verdugo R, et al. [Anti-Mullerian hormone serum levels in women with and without uterine fibroids]. Ginecol Obstet Mex. 2013;81:700–5.
  • Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol. 2005;106:1309–18.
  • McLucas B, Adler L, Perrella R. Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids. JACS. 2001;192:95–105.
  • van der Kooij SM, Hehenkamp WJ, Volkers NA, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2010;203:105; e1-13.
  • Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, et al. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess. 2008;12:1–248, iii.
  • Tropeano G, Di Stasi C, Amoroso S, Vizzielli G, Mascilini F, Scambia G. Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet Gnecol. 2012;120:269–76.
  • McLucas B, Voorhees WDIII. Results of UAE in women under 40 years of age. Minim Invas Ther Allied Technol. 2014;23:179–83.
  • Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR. 2007;188:176–81.
  • Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol. 2005;105:877–81.
  • Reed SD, Newton KM, Thompson LB, McCrummen BA, Warolin AK. The incidence of repeat uterine surgery following myomectomy. J Womens Health. 2006;15:1046–52.
  • Carpenter TT, Walker WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005;112:321–5.
  • Firouznia K, Ghanaati H, Sanaati M, Jalali AH, Shakiba M. Pregnancy after uterine artery embolization for symptomatic fibroids: a series of 15 pregnancies. AJR. 2009;192:1588–92.
  • Pinto Pabon I, Magret JP, Unzurrunzaga EA, Garcia IM, Catalan IB, Cano Vieco ML. Pregnancy after uterine fibroid embolization: follow-up of 100 patients embolized using tris-acryl gelatin microspheres. Fertil Steril. 2008;90:2356–60.
  • Pisco JM, Duarte M, Bilhim T, Cirurgiao F, Oliveira AG. Pregnancy after uterine fibroid embolization. Fertil Steril. 2011;95:1121; e5-8.
  • Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94:324–30.
  • Holub Z, Mara M, Kuzel D, Jabor A, Maskova J, Eim J. Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. Fertil Steril. 2008;90:1886–91.
  • Agdi M, Valenti D, Tulandi T. Intraabdominal adhesions after uterine artery embolization. Am J Obstet Gynecol. 2008;199:482; e1-3.
  • Goldberg J, Pereira L. Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy. Curr Opin Obstet Gynecol. 2006;18:402–6.
  • Al-Jabri S, Tulandi T. Management and prevention of pelvic adhesions. Semin Reprod Med. 2011;29:130–7.
  • Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau L. Fertility and pregnancy following pelvic arterial embolisation for postpartum haemorrhage. BJOG. 2010;117:84–93.
  • LaMorte AI, Lalwani S, Diamond MP. Morbidity associated with abdominal myomectomy. Obstet Gynecol. 1993;82:897–900.
  • Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril. 1993;60:956–62.
  • Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli AM. Uterine artery embolization versus myomectomy: impact on quality of life--results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc Interv Radiol. 2012;35:530–6.
  • Landi S, Zaccoletti R, Ferrari L, Minelli L. Laparoscopic myomectomy: technique, complications, and ultrasound scan evaluations. J Am Assoc Gynecol Laparosc. 2001;8:231–40.
  • Tulandi T, al-Took S. Endoscopic myomectomy. Laparoscopy and hysteroscopy. Obstet Gyn Clin N Am. 1999;26:135–48; viii.
  • Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. BJOG. 1991;98:385–9.
  • Lissoni A, Cormio G, Bonazzi C, Perego P, Lomonico S, Gabriele A, et al. Fertility-sparing surgery in uterine leiomyosarcoma. Gynecol Oncol. 1998;70:348–50.
  • Sudik R, Husch K, Steller J, Daume E. Fertility and pregnancy outcome after myomectomy in sterility patients. Eur J Obstet Gynecol Reprod Biol. 1996;65:209–14.
  • Acien P, Quereda F. Abdominal myomectomy: results of a simple operative technique. Fertil Steril. 1996;65:41–51.
  • Darai E, Dechaud H, Benifla JL, Renolleau C, Panel P, Madelenat P. Fertility after laparoscopic myomectomy: preliminary results. Hum Reprod. 1997;12:1931–4.
  • Dubuisson JB, Chapron C, Chavet X, Gregorakis SS. Fertility after laparoscopic myomectomy of large intramural myomas: preliminary results. Hum Reprod. 1996;11:518–22.
  • Bernard G, Darai E, Poncelet C, Benifla JL, Madelenat P. Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol. 2000;88:85–90.
  • McLucas B, Goodwin S, Adler L, Rappaport A, Reed R, Perrella R. Pregnancy following uterine fibroid embolization. Int J Gynaecol Obstet. 2001;74:1–7.
  • Berman JM. Intrauterine adhesions. Semin Reprod Med. 2008;26:349–55.
  • Gorny KR, Borah BJ, Brown DL, Woodrum DA, Stewart EA, Hesley GK. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol. 2014;25:1506–12.
  • Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol. 2014;26:151–61.
  • Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199–209.
  • Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. CVIR. 2008;31:73–85.
  • Lehmann P, Velez MP, Saumet J, Lapensee L, Jamal W, Bissonnette F, et al. Anti-Mullerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 2014;31:493–8.
  • Ryu RK, Chrisman HB, Omary RA, Miljkovic S, Nemcek AAJr, Saker MB, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. JVIR. 2001;12:1071–4.
  • Madhuri TK, Kamran W, Walker W, Butler-Manuel S. Synchronous uterine artery embolization and laparoscopic myomectomy for massive uterine leiomyomas. JSLS. 2010;14:120–2.
  • Nabeshima H, Murakami T, Sato Y, Terada Y, Yaegashi N, Okamura K. Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization. Tohoku J Exp Med. 2003;200:145–9.
  • Butori N, Tixier H, Filipuzzi L, Mutamba W, Guiu B, Cercueil JP, et al. Interest of uterine artery embolization with gelatin sponge particles prior to myomectomy for large and/or multiple fibroids. Eur J Radiol. 2011;79:1–6.
  • Ustunsoz B, Ugurel MS, Bozlar U, Duru NK, Ustunsoz A. Is uterine artery embolization prior to myomectomy for giant fibroids helpful? Diagn Interv Radiol. 2007;13:210–12.
  • Ngeh N, Belli AM, Morgan R, Manyonda I. Pre-myomectomy uterine artery embolisation minimises operative blood loss. BJOG. 2004;111:1139–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.